The global autoinjector market was valued at USD 1.35 Billion in 2024, driven by the rising demand and increasing regulatory approvals across the globe. The market is anticipated to grow at a CAGR of 12.80% during the forecast period of 2025-2034, with the values likely to reach USD 4.50 Billion by 2034.
Base Year
Historical Period
Forecast Period
In May 2024, Eisai Co., Ltd. and Nippon medac Co., Ltd. launched Japan’s first self-administrable methotrexate autoinjector, Metoject. Such innovations are expected to significantly support market growth in the forecast period.
A significant trend in the autoinjector devices market is the increasing focus on at-home administration. For instance, in January 2025, the FDA accepted the BLA for Leqembi's subcutaneous autoinjector, enabling Alzheimer's disease treatment at home.
The market is driven by technological advancements, including smart features, and expanding healthcare access in emerging regions, boosting demand for efficient, affordable drug delivery solutions.
Compound Annual Growth Rate
12.8%
Value in USD Billion
2025-2034
Autoinjector Market Outlook
*this image is indicative*
Autoinjector devices are medical instruments engineered to deliver accurate doses of medication subcutaneously or intramuscularly, commonly used for chronic conditions or emergency interventions. The market is experiencing significant growth, driven by the increasing prevalence of chronic diseases, rising demand for self-administration, and ongoing technological advancements that improve usability, safety, and patient compliance across various therapeutic applications.
Rising Demand to Accelerate Market Expansion
The growing global demand for self-injection therapies is driving the expansion of manufacturing infrastructure in the market. For instance, in April 2025, SHL Medical inaugurated a manufacturing facility in South Carolina. The site will manufacture autoinjectors used in top-selling medications for endocrine, metabolic, dermatological, and musculoskeletal disorders. Such a move highlights the industry's push to scale production capacity and meet rising therapeutic needs, accelerating overall market growth.
New Product Launches to Meet Rising Autoinjector Market Demand
The introduction of advanced treatment options continues to propel the market growth of the autoinjector devices. A notable example is the introduction of the Nanozora® 30 mg Autoinjector for subcutaneous injection by Taisho Pharmaceutical in January 2024 . This device offers patients an easy-to-use solution for rheumatoid arthritis (RA) treatment. The prefilled, single-use autoinjector ensures greater convenience and safety by locking the needle cover after injection, preventing accidental needle sticks. As the demand for patient-friendly, efficient drug delivery systems rises, such advancements are expected to significantly contribute to the continued growth and expansion of the autoinjector market.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Autoinjector Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Volume
Market Breakup by Technology
Market Breakup by Route of Administration
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Reusable Devices is Poised to Lead Market by Type
The market is divided into disposable and reusable, based on the type. Reusable devices are expected to hold a substantial share in the market due to their cost-effectiveness, environmental sustainability, and growing adoption in healthcare facilities seeking long-term value. Their durability and compatibility with sterilization processes make them a preferred choice, particularly in high-volume settings. As healthcare systems emphasize efficiency and waste reduction, the demand for reusable options is projected to increase steadily.
Autoinjector Market Segmentation by Route of Administration to Undergo Significant Growth
Based on the route of administration, the market is segmented into subcutaneous and intramuscular. The subcutaneous route is anticipated to grow significantly due to its ease of administration, improved patient compliance, and suitability for self-injection. It supports controlled drug absorption and is commonly used for biologics and chronic therapies. As demand for home-based treatments rises, subcutaneous administration is becoming increasingly preferred across various therapeutic areas.
The market demonstrates robust growth across key regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Each region contributes uniquely, with North America holding a major share due to its advanced healthcare infrastructure and rising demand for self-administered drug delivery systems. In June 2024, Gerresheimer announced a USD 180 million expansion in Peachtree City, Georgia, to increase production capacity for autoinjectors and related medical systems, reinforcing its leadership in the United States market.
The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Pfizer Inc., established in 1849 and headquartered in New York City, is a global biopharmaceutical leader. In October 2024, Pfizer introduced Hympavzi (marstacimab-hncq), the first once-weekly subcutaneous hemophilia treatment in the United States administered via a pre-filled autoinjector pen. This innovation highlights Pfizer’s commitment to advancing patient-centric, self-administered therapies for chronic conditions.
Eli Lilly and Company, headquartered in Indianapolis, Indiana, plays a significant role in the autoinjector devices market through products like Zepbound (tirzepatide), an injectable treatment for obesity. In 2024, Lilly expanded access by launching Zepbound in single-dose vials and autoinjector pens, enhancing affordability and availability for patients managing chronic weight conditions.
SHL Medical specializes in advanced drug delivery systems, particularly autoinjectors and was established in 1989. Its flagship product, the Molly autoinjector , is a single-dose, disposable device designed for subcutaneous administration. Built on a modular platform, Molly supports high-volume manufacturing and customization, reinforcing SHL's role in accelerating autoinjector development for global pharmaceutical partners.
Headquartered in Burgdorf, Switzerland, Ypsomed is a leading developer and manufacturer of innovative injection and infusion systems. The company plays a prominent role in the autoinjector devices market with its YpsoMate platform, including products like YpsoMate, YpsoMate 2.25, YpsoMate 5.5, and SmartPilot. These devices support safe, user-friendly, and connected drug delivery solutions.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Amgen Inc., Sanofi, Teva Pharmaceutical, Biogen Idec, Mylan N.V., and Gerresheimer.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Volume |
|
| Breakup by Technology |
|
| Breakup by Route of Administration |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
